All Disease Treatment & Prevention articles
-
NewsGut bacteria changes at the earliest stages of inflammatory bowel disease
People newly diagnosed with the most common IBD subtypes, Crohn’s disease and ulcerative colitis, lose beneficial anaerobic bacteria that help with digestion of complex carbohydrates. Patients instead experience a rise in oxygen-tolerant bacteria from the mouth that travel in the gut.
-
NewsOral bacterium tied to disability severity in multiple sclerosis
A research team has conducted a study with findings that suggest a potential association between the relative abundance of Fusobacterium nucleatum (F. nucleatum), a bacterium found in the mouth, and disease severity in multiple sclerosis (MS) patients.
-
NewsResearch reveals how ancient viral DNA shapes early embryonic development
New research focuses on a viral transposable element called MERVL. This element becomes highly active for a short window of time when a mouse embryo reaches the 2-cell stage – the point at which a fertilised egg has divided into two cells and switches on its own genome for the first time.
-
NewsResearch links tumor bacteria to immunotherapy resistance in head and neck cancer
Two new studies reveal that elevated levels of bacteria in the tumor microenvironment suppress immune response, driving resistance to immunotherapy in patients with head and neck squamous cell carcinoma.
-
NewsThe gut bacteria that put the brakes on weight gain in mice
Research has identified a specific type of gut bacteria, called Turicibacter, that improves metabolic health and reduces weight gain in mice on a high-fat diet. People with obesity tend to have less Turicibacter, suggesting that the microbe may promote healthy weight in humans as well.
-
NewsFor certain life-essential proteins in E. coli, repair is more likely
A new study shows that E. coli proteins containing a specific structure are more likely to misfold and, if they are required the bacteria’s survival, more likely to be repaired.
-
NewsCancer-fighting bacterial product ‘cocktails’ may offer personalized treatment
Bacteria may be the next frontier in cancer treatment, according to researchers who devised a new approach of creating bacteria-derived mixtures — or cocktails — to help fight bladder cancer. They found that the cocktails significantly boost the immune system’s ability to fight cancer.
-
NewsCOVID-19 leaves a lasting mark on the human brain
COVID-19 does not just affect the respiratory system, but also significantly alters the brain in people who have fully recovered from the infectious disease, highlighting the long-term neurological impact of the virus.
-
NewsWho is more likely to get long COVID?
Scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to experience debilitating symptoms long after their initial infection.
-
NewsA fatal mix-up: How certain gut bacteria drive multiple sclerosis
If gut bacteria are too similar to the protective layer of nerves, they can misdirect the immune system and cause it to attack its own nervous system. This mechanism can accelerate the progression of multiple sclerosis.
-
NewsStreptococcus suis serotype 2 collagenase-like protease promotes meningitis by increasing blood-brain barrier permeability
Streptococcus suis serotype 2 (SS2) is an emerging zoonotic pathogen that causes meningitis in humans and pigs. Researchers have investigated the role and mechanism of the SS2 Clp in promoting the passage of the bacterium across the blood-brain barrier (BBB).
-
NewsHarmless Klebsiella strain shows powerful protection against gut infections in Inflammatory Bowel Disease (IBD) model
A new study demonstrates that a harmless strain of Klebsiella can eliminate infections and reduce gut inflammation in mouse models of inflammatory bowel disease (IBD).
-
NewsCould hidden infections be fueling long COVID?
For millions suffering from long COVID, their persistent breathlessness, brain fog and fatigue remain a maddening mystery, but microbiologists think they may have cracked the case. The review argues that co-infections acquired before or during COVID could cause symptoms to persist indefinitely for many people.
-
NewsOlder age, chronic kidney disease and cerebrovascular disease linked with increased risk for paralysis and death after West Nile virus infection
Older people with a history of chronic kidney disease or conditions affecting blood flow to the brain such as stroke face about double the risk for developing neuroinvasive disease that can lead to paralysis and death following infection with West Nile virus, new research finds.
-
NewsOpioid use linked to higher risk of C. difficile infection
New research from the University of Georgia suggests that opioid use could make patients more vulnerable to infections. The meta-analysis examined four studies of almost 120,000 patients. The researchers found that about 31% of patients who were prescribed and taking opioids caught C. diff, compared to 17% of patients who weren’t using them.
-
NewsStudy reveals promising gut-targeted therapy for C. difficile infections
Researchers have uncovered how the body’s bile acids bind to block C. diff’s most dangerous toxin. The research has informed the development of a new compound that can protect against C. diff in preclinical models, offering hope for safer, more effective treatments.
-
NewsIncreased risk of severe bacterial infection after high teenage BMI
High BMI and poor physical fitness during later adolescence increase the risk of both contracting and dying from sepsis and other severe bacterial infections in adulthood, according to a study.
-
NewsHow polyphenol-rich diets promote healthy aging through microbiome and metabolome modulation
New findings suggest that polyphenol-rich diets can serve as a simple, safe, and effective nutritional strategy to counteract inflammation and support healthy aging.
-
NewsEverolimus alleviates ulcerative colitis via inflammation suppression and microbiota remodeling
A new study reveals how targeting the CLEC4E receptor and reshaping the gut metabolite axis offers a promising therapeutic avenue for inflammatory bowel disease.
-
NewsInside the gut: What our poo could tell us about our diet, gut microbes and health
Researchers have found that molecules in stool samples can accurately reflect what people eat and how their gut microbiome responds, offering a potential new tool to study nutrition and its impact on health.